Multispecific Antibodies Market Research, Drug Sales, Price & Clinical Trials Insights 2023-2029: 13 Approved, 900 Multispecific Antibodies in Clinical Trials by Company, Country, Indication, & Phase
August 09, 2024 04:16 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
Epidermolysis Bullosa Therapeutics Research 2024: Present Scenario and Growth Prospects - Comprehensive Insights About 22+ Companies and 24+ Pipeline Drugs
July 31, 2024 09:14 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Epidermolysis Bullosa - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Androgenic Alopecia (AGA) Pipeline and Competitive Landscape Insights, 2024 - Identify the Categories Presenting the Maximum Opportunities for Consolidations, Investments, and Strategic Partnerships
July 30, 2024 08:04 ET
|
Research and Markets
Dublin, July 30, 2024 (GLOBE NEWSWIRE) -- The "Androgenic Alopecia: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of...
7MM Spinal Muscular Atrophy Opportunity Assessment and Forecasts 2023-2033 Featuring Eli Lilly and Co, Biogen, F. Hoffmann-La Roche,d Novartis, Scholar Rock, & Biohaven
July 29, 2024 10:28 ET
|
Research and Markets
Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy: Opportunity Assessment and Forecast 2023-2033" report has been added to ResearchAndMarkets.com's offering. The diagnosed...
Fibromyalgia Therapeutics Global Strategic Business Report 2024-2030 Featuring Allergan, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly and Co, Innovative Med Concepts, Pfizer, SWITCHBIOTECH, Zynerba
July 22, 2024 10:48 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Fibromyalgia Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
US, Germany and the UK Niemann Pick Type C Opportunity Assessment and Forecast 2021-2023 & 2024-2031 Featuring J&J, Piramal Enterprises, IntraBio, Zevra Therapeutics, Azafaros, & Cyclo Therapeutics
July 19, 2024 06:51 ET
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Niemann Pick Type C: Opportunity Assessment and Forecast - Update" report has been added to ResearchAndMarkets.com's offering.The prevalence of...
Antivenoms Global Market Insights and Outlook 2024-2030: A $2.3 Billion Opportunity with Snake Antivenoms Accounting for ~87% Share of the Total Market - BTG PLC Leads the Competition, Followed by CSL Ltd.
July 18, 2024 09:08 ET
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Antivenoms - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antivenoms is...
Amyotrophic Lateral Sclerosis Opportunity Assessment and Forecasts 2019-2024 & 2024-2029 - Focus on US, France, Germany, Italy, Spain, UK, Japan and Canada
July 17, 2024 09:47 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update" report has been added to ResearchAndMarkets.com's offering.This...
United States Hereditary Angioedema Therapeutics Market Soars to New Heights, Projections to 2029
July 16, 2024 11:22 ET
|
Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to...
Global Glucosamine Business Analysis Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023 - Emerging Markets and Growth Opportunities in Developing Regions
July 15, 2024 05:31 ET
|
Research and Markets
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Glucosamine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Glucosamine is...